Cards Acccepted | 5% OFF Crypto | 3rd Party Testing | FREE Worldwide Shipping $400+
Menu
Cart
PT-141 10 mg lyophilized vial
lyophilized peptide vial box (blue cap)
pt-141 certificate of analysis
pt-141 hplc
PT-141 (Bremelanotide) 10mg - 10 Vial Box - Image 5

PT-141 (Bremelanotide) 10mg – 10 Vial Box

$194.00

Cost per vial $: 19.4

Buy PT-141 10 mg (one 10-vial box). All orders are shipped wholesale in unbranded packaging. Worldwide 7 – 14 day shipping to the USA, UK, AUS & NZ.

Bulk discounts
Quantity Bulk Discount Price
25%$184.30
3-57%$180.42
6-1010%$174.60
SKU: PT14110Category:

Description

PT-141 (Bremelanotide) is a synthetic peptide known for its potential to enhance sexual desire and arousal by activating specific receptors in the brain. It works differently from other treatments by targeting the central nervous system rather than the vascular system. Researchers are particularly interested in its potential benefits for addressing sexual dysfunction. PT-141 is the generic peptide version of Vyleesi.

Minimum order quantity: one box (10 vials x 10 mg). Photo for illustration purposes only.

 

 

Additional information

Purity

≥99.0%

Molar Mass

1025. g/mol

Molecular Formula

C₅₀H₆₈N₁₄O₁₀

Sequence

Ac-Nle-cyclo(-Asp-His-D-Phe-Arg-Trp-Lys-OH)

Cost per vial $

19.4

  1. Molinoff, P. B., et al. "PT‐141: A melanocortin agonist for the treatment of sexual dysfunction." Annals of the New York Academy of Sciences 994.1 (2003): 96-102.
  2. Diamond, L. E., et al. "Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction." International journal of impotence research 16.1 (2004): 51-59.
  3. Rosen, R. C., et al. "Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra®." International journal of impotence research 16.2 (2004): 135-142.
  4. Diamond, L. E., et al. "Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response." Urology 65.4 (2005): 755-759.
  5. Diamond, Lisa E., et al. "An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT‐141), a melanocortin receptor agonist." The journal of sexual medicine 3.4 (2006): 628-638.

PT-141 CoA 2024

PT-141 HPLC

Related products